Clinical trials
Observational Amyloid Neuropathies, Familial trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
| Completed | 5 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alnylam Pharmaceuticals | 3 |
| Mayo Clinic | 2 |
| University of Texas Southwestern Medical Center | 2 |
| AstraZeneca | 1 |
| Cedars-Sinai Medical Center | 1 |
| Columbia University | 1 |
| Lorena Saelices | 1 |
| Mathew S. Maurer, MD | 1 |
| Midwest Heart & Vascular Specialists | 1 |
| Montefiore Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amyloid Neuropathies, Familial | 20 |
| Amyloidosis | 10 |
| Amyloidosis, Familial | 5 |
| Polyneuropathies | 4 |
| Amyloid Neuropathies | 3 |
| Cardiomyopathies | 3 |
| Heart Failure | 3 |
| Alzheimer Disease | 2 |
| Cardiomyopathy, Hypertrophic | 2 |
| Immunoglobulin Light-chain Amyloidosis | 2 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.